2-Bromo-4-fluoro-3-methyl-1-nitrobenzene, 98%, 25g

5-Iodo-1H-indazole-3-carboxylic acid, 95.0%, 5g

1-Methyl-1H-pyrazole-4-boronic acid, 95.0%, 100g

3-(Aminomethyl)-4-methoxy-6-methylpyridin-2(1H)-one hydrochloride, 98%, 100mg

(R)-4-Bromo-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 100mg

TERT-BUTYL (3-(PIPERIDIN-2-YL)PHENYL)CARBAMATE, 95.0%, 1g

(3-(Trifluoromethyl)pyrrolidin-3-yl)methanol, 100mg

Methyl 4-hydroxybenzoate, ROTICHROM® Working Standard, 100 mg, glass packaging

TERT-BUTYL 2-(HYDROXYMETHYL)-4-METHYLPIPERAZINE-1-CARBOXYLATE, 95%, 1g

Methyl 4-methyl-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-carboxylate, 97%, 250mg

2,4,6-Trifluoro-3-methoxybenzaldehyde, 5g

5-Chloropyrimidine-4-carboxylic acid, 95.0%, 250mg

iScope IS.1158-PLPHi Biocular for phase contrast with Plan phase IOS objectives and Rackless cross stage (infinity - ergonomic tilting head)